MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$33,432K
Net Income
-$67,023K
Net Profit Margin
-200.48%
EPS
-$2.32
Unit: Thousand (K) dollars
Revenue Breakdown
Gross product revenue
Provisions for product revenue
License And Other
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue from contract with customer, license and other revenue
33,432
35,066
34,079
44,044
Cost of sales
1,085
1,345
1,484
2,113
Research and development
28,957
33,797
27,667
30,544
Selling, general and administrative
25,916
26,684
22,772
26,607
Total operating expenses
55,958
61,826
51,923
59,264
Loss from operations
-22,526
-26,760
-17,844
-15,220
Interest income
722
511
607
553
Interest expense
13,144
12,553
12,619
11,008
(loss) gain on extinguishment of debt
-
-
-62,365
0
Other (expense) income, net
-32,075
16,411
-10,044
-7,418
Total other expense, net
-44,497
4,369
-84,421
-17,873
Loss before income taxes
-67,023
-22,391
-102,265
-33,093
Income tax provision
0
1
-67
34
Net loss
-67,023
-22,392
-102,198
-33,127
Basic EPS
-2.32
-1.02
-5,683.666
-3.82
Diluted EPS
-2.32
-1.24
-5,683.666
-3.82
Basic Average Shares
28,938
22,014
17,981
8,669
Diluted Average Shares
28,938
24,715
17,981
8,669
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$67,023K
(-79.92%↓ Y/Y)
Gross product revenue
$41,944K
Loss before income
taxes
-$67,023K
(-80.11%↓ Y/Y)
Product
$30,776K
License And Other
$2,656K
Provisions for product
revenue
$11,168K
Total other expense,
net
-$44,497K
(-246.96%↓ Y/Y)
Loss from operations
-$22,526K
(7.63%↑ Y/Y)
Interest income
$722K
(17.78%↑ Y/Y)
Revenue from contract
with customer,...
$33,432K
(-11.86%↓ Y/Y)
Other (expense)
income, net
-$32,075K
(-1351.36%↓ Y/Y)
Interest expense
$13,144K
(17.06%↑ Y/Y)
Total operating
expenses
$55,958K
(-10.20%↓ Y/Y)
Research and development
$28,957K
(-11.68%↓ Y/Y)
Selling, general and
administrative
$25,916K
(-8.99%↓ Y/Y)
Cost of sales
$1,085K
(3.24%↑ Y/Y)
Buy us a coffee
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)